4-(3-butoxy-4-methoxybenzyl)-2-imidazolidinone has been researched along with azides in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Craven, PA; Davis, BB; DeRubertis, FR; Zenser, TV | 1 |
| Kammer, GM; Mitchell, E | 1 |
| Averill, LE; Kammer, GM; Stein, RL | 1 |
3 other study(ies) available for 4-(3-butoxy-4-methoxybenzyl)-2-imidazolidinone and azides
| Article | Year |
|---|---|
Differential inhibition of cyclic AMP and cyclic GMP hydrolysis in rat renal cortex.
Topics: 2',3'-Cyclic-Nucleotide Phosphodiesterases; 4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone; Animals; Azides; Carbachol; Cyclic AMP; Cyclic GMP; Kidney Cortex; Parathyroid Hormone; Phosphoric Diester Hydrolases; Rats; Theophylline; Xanthines | 1977 |
Impaired mobility of human T lymphocyte surface molecules during inactive systemic lupus erythematosus. Relationship to a defective cAMP pathway.
Topics: 4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone; Adenosine; Adult; Antigens, Surface; Azides; Colforsin; Cyclic AMP; Female; Humans; Immunologic Capping; Lupus Erythematosus, Systemic; Male; Receptors, Cyclic AMP; T-Lymphocytes | 1988 |
Control of human T-lymphocyte interleukin-2 production by a cAMP-dependent pathway.
Topics: 4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone; Adenylyl Cyclases; Adolescent; Adult; Aged; Azides; Calcimycin; Cell Line; Colforsin; Cyclic AMP; Dose-Response Relationship, Immunologic; Female; Humans; Immunosuppressive Agents; Interleukin-1; Interleukin-2; Lymphocyte Activation; Male; Middle Aged; Phosphorylation; T-Lymphocytes; Tetradecanoylphorbol Acetate | 1988 |